Abstract
Purpose
Fibromyalgia syndrome (FMS) is associated with psychological distress. The recent revision of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) raises the question of whether FMS is classifiable as “somatic symptom disorder” (SSD) and consequently as a mental disorder. To address this, the present ambulatory assessment study focuses on the everyday life occurrence of SSD symptoms in FMS and their predictive value concerning severity indicators of widespread pain.
Method
Ambulatory data were assessed six times daily on 14 consecutive days via iPod. Twenty-eight women suffering from FMS indicated symptoms associated with SSD (somatic illness beliefs, health anxiety, time/energy devoted to pain, or health concerns) and momentary pain levels. Questionnaires regarding potential covariates (such as somatization, depression, health status) were completed at two additional sessions in the research laboratory.
Results
On average, SSD symptoms occurred three to four times daily and were mild to moderate in severity. Furthermore, these symptoms were both concurrently and prospectively associated with momentary pain intensity and subjective impairment by pain. Twenty percent of the variance in pain intensity and 28 % of the variance in subjective impairment were explained by momentary variables (SSD symptoms and intake of pain medication). Eighty-two percent of persons with FMS fulfilled the psychological SSD criterion when considering everyday occurring symptoms with at least mild severity.
Conclusion
FMS might be diagnosed as a mental disorder according to DSM-5 in many cases. SSD symptoms proved to have predictive value for FMS severity and may thus have clinical relevance for diagnostic, prognostic, and intervention purposes.
Similar content being viewed by others
References
Häuser W, Zimmer C, Felde E, Köllner V. What are the key symptoms of fibromyalgia? Results of a survey of the German Fibromyalgia Association. Schmerz. 2008;22:176–83.
Hoffman DL, Dukes EM. The health status burden of people with fibromyalgia: a review of studies that assessed health status with the SF-36 or the SF-12. Int J Clin Pract. 2008;62:115–26.
Knight T, Schaefer C, Chandran A, Zlateva G, Winkelmann A, Perrot S. Health-resource use and costs associated with fibromyalgia in France, Germany, and the United States. Clinicoecon Outcomes Res. 2013;5:171–80.
Warren JW, Clauw DJ. Functional somatic syndromes: sensitivities and specificities of self-reports of physician diagnosis. Psychosom Med. 2012;74:891–5.
McBeth J, Macfarlane GJ, Hunt IM, Silman AJ. Risk factors for persistent chronic widespread pain: a community-based study. Rheumatology (Oxford). 2001;40:95–101.
Muller A, Hartmann M, Eich W. Health care utilization in patients with fibromyalgia syndrome (FMS). Schmerz. 2000;14:77–83.
Fink P, Rosendal M, Olesen F. Classification of somatization and functional somatic symptoms in primary care. Aust N Z J Psychiatry. 2005;39:772–81.
Häuser W, Henningsen P. Fibromyalgia syndrome: a somatoform disorder? Eur J Pain. 2014;18:1052–9.
Henningsen P, Zipfel S, Herzog W. Management of functional somatic syndromes. Lancet. 2007;369:946–55.
Kroenke K. Somatoform disorders and recent diagnostic controversies. Psychiatr Clin North Am. 2007;30:593–619.
Fink P, Schröder A. One single diagnosis, bodily distress syndrome, succeeded to capture 10 diagnostic categories of functional somatic syndromes and somatoform disorders. J Psychosom Res. 2010;68:415–26.
Yunus MB. Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness. Semin Arthritis Rheum. 2008;37:339–52.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders, (5th ed.; DSM-5). Arlingten, VA: American Psychiatric Association; 2013.
Ebner-Priemer UW, Trull TJ. Ambulatory assessment: an innovative and promising approach for clinical psychology. Eur Psychol. 2009;14:109–19.
Wolfe F, Braehler E, Hinz A, Haeuser W. Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population. Arthrit Care Res. 2013;65:777–85.
Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Häuser W, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR preliminary diagnostic criteria for fibromyalgia. J Rheumatol. 2011;38:1113–22.
Häuser W, Jung E, Erbslöh-Möller B, Gesmann M, Kühn-Becker H, Petermann F, Langhorst J, Weiss T, Winkelmann A, Wolfe F. Validation of the Fibromyalgia Survey Questionnaire within a cross-sectional survey. PLoS One. 2012;7:e37504.
Offenbaecher M, Waltz M, Schoeps P. Validation of a German version of the Fibromyalgia Impact Questionnaire (FIQ-G). J Rheumatol. 2000;27:1984–8.
Löwe B, Spitzer RL, Zipfel S, Herzog W. PHQ-D - Gesundheitsfragebogen für Patienten [German version of the Patient Health Questionnaire]. Karlsruhe: Pfizer; 2002.
Kroenke K, Spitzer RL, Williams JB, Loewe B. The Patient Health Questionnaire somatic, anxiety, and depressive symptom scales: a systematic review. Gen Hosp Psychiatry. 2010;32:345–59.
Kroenke K, Spitzer RL, Williams JB. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med. 2002;64:258–66.
Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606–13.
Woltman H, Feldstain A, MacKay JC, Rocchi M. An introduction to hierarchical linear modeling. TQMP. 2012;8:52–69.
Brosschot JF, Aarsse HR. Restricted emotional processing and somatic attribution in fibromyalgia. Int J Psychiat Med. 2001;31:127–46.
Van Wilgen CP, van Ittersum MW, Kaptein AA, van Wijhe M. Illness perceptions in patients with fibromyalgia and their relationship to quality of life and catastrophizing. Arthritis Rheum. 2008;58:3618–26.
Cedraschi C, Girard E, Luthy C, Kossovsky M, Desmeules J, Allaz A-F. Primary attributions in women suffering fibromyalgia emphasize the perception of a disruptive onset for a long-lasting pain problem. J Psychosom Res. 2013;74:265–9.
Tuzer V, Bulut SD, Bastug B, Kayalar G, Goka E, Bestepe E. Causal attributions and alexithymia in female patients with fibromyalgia or chronic low back pain. Nord J Psychiat. 2011;65:138–44.
Epstein SA, Kay G, Clauw D, Heaton R, Klein D, Krupp L, Kuck J, Leslie V, Masur D, Wagner M, Waid R, Zisook S. Psychiatric disorders in patients with fibromyalgia. A multicenter investigation. Psychosomatics. 1999;40:57–63.
Sansone RA, Levengood JV, Sellbom M. Psychological aspects of fibromyalgia: research vs. clinician impressions. J Psychosom Res. 2004;56:185–8.
Robbins JM, Kirmayer LJ, Kapusta MA. Illness worry and disability in fibromyalgia syndrome. Int J Psychiat Med. 1990;20:49–63.
Sánchez AI, Martínez MP, Miró E, Medina A. Predictors of the pain perception and self-efficacy for pain control in patients with fibromyalgia. Span J Psychol. 2011;14:366–73.
Aggarwal VR, McBeth J, Zakrzewska JM, Lunt M, Macfarlane GJ. The epidemiology of chronic syndromes that are frequently unexplained: do they have common associated factors? Int J Epidemiol. 2006;35:468–76.
Chen AT. Information seeking over the course of illness: the experience of people with fibromyalgia. Musculoskeletal Care. 2012;10:212–20.
Sanchez RJ, Uribe C, Li H, Alvir J, Deminski M, Chandran A, Palacio A. Longitudinal evaluation of health care utilization and costs during the first three years after a new diagnosis of fibromyalgia. Curr Med Res Opin. 2011;27:663–71.
Berger A, Sadosky A, Dukes E, Martin S, Edelsberg J, Oster G. Characteristics and patterns of healthcare utilization of patients with fibromyalgia in general practitioner settings in Germany. Curr Med Res Opin. 2008;24:2489–99.
Al-Allaf AW. Work disability and health system utilization in patients with fibromyalgia syndrome. JCR-J Clin Rheumatol. 2007;13:199–201.
Hazlett RL, Haynes SN. Fibromyalgia: a time-series analysis of the stressor-physical symptom association. J Behav Med. 1992;15:541–58.
Karsdorp PA, Vlaeyen JWS. Active avoidance but not activity pacing is associated with disability in fibromyalgia. Pain. 2009;147:29–35.
Nicholl BI, Macfarlane GJ, Davies KA, Morriss R, Dickens C, McBeth J. Premorbid psychosocial factors are associated with poor health-related quality of life in subjects with new onset of chronic widespread pain—results from the EPIFUND study. Pain. 2009;141:119–26.
Kirmayer LJ, Taillefer S. Somatoform disorders. In: Turner SM, Hersen M, editors. Adult psychopathology and diagnosis. New York: John Wiley; 1997.
Okifuji A, Turk DC. Fibromyalgia: search for mechanism and effective treatment. In: Gatchel RJ, Turk DC, editors. Psychosocial factors in pain: critical perspectives. New York: Guilford Press; 1999. p. 227–46.
Rief W, Martin M. How to use the new DSM-5 somatic symptom disorder diagnosis in research and practice: a crititcal evaluation and a proposal for modifications. Annu Rev Clin Psychol. 2014;10:339–67.
Häuser W, Burgmer M, Köllner V, Schaefert R, Eich W, Hausteiner-Wiehle C, Henningsen P. Fibromyalgia syndrome as a psychosomatic disorder—diagnosis and therapy according to current evidence-based guidelines. Z Psychosom Med Psychother. 2013;59:132–52.
Häuser W, Thieme K, Turk DC. Guidelines on the management of fibromyalgia syndrome—a systematic review. Eur J Pain. 2010;14:5–10.
Maas CJM, Hox JJ. Sufficient sample sizes for multilevel modeling. Eur J Res Method Behav Soc Sci. 2005;1:86–92.
Fahrenberg J, Myrtek M, Pawlik K, Perrez M. Ambulatory assessment—monitoring behavior in daily life settings. Eur J Psychol Assess. 2007;23:206–13.
Häuser W, Schild S, Kosseva M, Hayo S, von Wilmowski H, Alten R, et al. Validation of the German version of the Regional Pain Scale for the diagnosis of fibromyalgia syndrome. Schmerz. 2010;24:226–35.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical Approval
The study protocol was approved by the local institutional review board (Department of Psychology, University of Marburg, Germany). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Funding
The authors acknowledge funding by the Volkswagen Foundation and the Swiss National Science Foundation. Participant reimbursements were funded by the Philipps-Universität Marburg.
Conflict of Interest
The authors declare that they have no conflict of interest.
Ethical Approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed Consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Klaus, K., Fischer, S., Doerr, J.M. et al. Classifying Fibromyalgia Syndrome as a Mental Disorder?—An Ambulatory Assessment Study. Int.J. Behav. Med. 24, 230–238 (2017). https://doi.org/10.1007/s12529-016-9603-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12529-016-9603-6